English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, September 6, 2022
Sirnaomics受邀出席第三届富瑞亚洲论坛并作演讲
Sirnaomics受邀出席第三屆富瑞亞洲論壇並作演講
Sirnaomics to Present at 3rd Annual Jefferies Asia Forum
Monday, August 29, 2022
Sirnaomics核心产品STP705在治疗皮肤基底细胞癌II期临床试验组别中实现100%完全清除
Sirnaomics核心產品STP705在治療皮膚基底細胞癌II期臨床試驗組別中實現100%完全清除
Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
Friday, August 26, 2022
Sirnaomics推进基于GalAhead(TM)递送平台的RNAi疗法,用于治疗补体介导相关疾病
Sirnaomics推進基於GalAhead(TM)遞送平台的RNAi療法,用於治療補體介導相關疾病
Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases
Monday, August 22, 2022
Sirnaomics获纳入恒生指数系列成份股

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575